journal
Journals Applied Health Economics and H...

Applied Health Economics and Health Policy

https://read.qxmd.com/read/38862769/cost-of-carbon-in-the-total-cost-of-healthcare-procedures-a-methodological-challenge
#1
JOURNAL ARTICLE
Paul-Simon Pugliesi, Laurie Marrauld, Catherine Lejeune
Economic evaluations aim to compare the costs and the results of health strategies to guide the public decision-making process. Cost estimation is, thus, a cornerstone of this approach. At present, few national evaluation agencies recommend incorporating the cost of greenhouse gas (GHG) emissions from healthcare actions into the calculation of healthcare costs. Our main goal is to describe and discuss the methodology for integrating the cost of GHG emissions into the field of applied economic evaluations. To estimate this cost, three steps are required: (1) identifying and quantifying the physical flows linked to the production and management of the outputs of healthcare interventions, (2) estimating the quantity of GHG that can be attributed to each physical flow, and (3) valuing these GHG emissions in monetary terms...
June 11, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38861109/the-cost-effectiveness-of-primary-prevention-interventions-for-skin-cancer-an-updated-systematic-review
#2
JOURNAL ARTICLE
Louisa G Collins, Ryan Gage, Craig Sinclair, Daniel Lindsay
OBJECTIVE: Preventing the onset of skin malignancies is feasible by reducing exposure to ultraviolet radiation. We reviewed published economic evaluations of primary prevention initiatives in the past decade, to support investment decisions for skin cancer prevention. METHODS: We assessed cost-effectiveness, cost-utility and benefit-cost analyses published from 1 September 2013. Seven databases were searched on 18 July 2023 and updated on 15 November 2023. Studies must have reported outcomes in terms of monetary costs, life years, quality-adjusted life years or variant thereof...
June 11, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38858344/employing-real-world-evidence-for-the-economic-evaluation-of-non-vitamin-k-antagonist-oral-anticoagulants-in-patients-with-atrial-fibrillation-in-thailand
#3
JOURNAL ARTICLE
Rungroj Krittayaphong, Unchalee Permsuwan
BACKGROUND: This study aimed to assess the cost-effectiveness of non-vitamin K antagonist oral anticoagulants (NOACs) in comparison with warfarin using data from real practice based on the perspective of the health care system in Thailand. METHODS: A four-state Markov model encompassing well-controlled atrial fibrillation (AF), stroke and systemic embolism, major bleeding and death was utilised to forecast clinical and economic outcomes. Transitional probabilities, direct medical costs and utilities were derived from the real-world data of the 'COOL-AF Thailand' registry, Thailand's largest nationwide registry spanning 27 hospitals...
June 10, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38837100/pricing-procurement-and-reimbursement-policies-for-incentivizing-market-entry-of-novel-antibiotics-and-diagnostics-learnings-from-10-countries-globally
#4
REVIEW
Sabine Vogler, Katharina Habimana, Manuel Alexander Haasis, Stefan Fischer
BACKGROUND: Fostering market entry of novel antibiotics and enhanced use of diagnostics to improve the quality of antibiotic prescribing are avenues to tackle antimicrobial resistance (AMR), which is a major public health threat. Pricing, procurement and reimbursement policies may work as AMR 'pull incentives' to support these objectives. This paper studies pull incentives in pricing, procurement and reimbursement policies (e.g., additions to, modifications of, and exemptions from standard policies) for novel antibiotics, diagnostics and health products with a similar profile in 10 study countries...
June 5, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38796659/cost-effectiveness-of-test-and-treat-strategies-to-reduce-the-antibiotic-prescription-rate-for-acute-febrile-illness-in-primary-healthcare-clinics-in-africa
#5
JOURNAL ARTICLE
Pim W M van Dorst, Simon van der Pol, Piero Olliaro, Sabine Dittrich, Juvenal Nkeramahame, Maarten J Postma, Cornelis Boersma, Antoinette D I van Asselt
BACKGROUND: Inappropriate antibiotic use increases selective pressure, contributing to antimicrobial resistance. Point-of-care rapid diagnostic tests (RDTs) would be instrumental to better target antibiotic prescriptions, but widespread implementation of diagnostics for improved management of febrile illnesses is limited. OBJECTIVE: Our study aims to contribute to evidence-based guidance to inform policymakers on investment decisions regarding interventions that foster more appropriate antibiotic prescriptions, as well as to address the evidence gap on the potential clinical and economic impact of RDTs on antibiotic prescription...
May 25, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38771430/informing-structural-assumptions-for-three-state-oncology-cost-effectiveness-models-through-model-efficiency-and-fit
#6
JOURNAL ARTICLE
Dominic Muston
The characteristics and relative strengths and weaknesses of partitioned survival models (PSMs) and state transition models (STMs) for three state oncology cost-effectiveness models have previously been studied. Despite clear and longstanding economic modeling guidelines, more than one structure is rarely presented, and the choice of structure appears correlated more with audience or precedent than disease, decision problem, or available data. One reason may be a lack of guidance and tools available to readily compare measures of internal validity such as the model fit and efficiency of different structures, or sensitivity of results to those choices...
May 21, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38758509/cost-effectiveness-of-adding-fenfluramine-to-standard-of-care-for-patients-with-dravet-syndrome-in-sweden
#7
JOURNAL ARTICLE
Chiara Malmberg, Magnus Värendh, Patric Berling, Mata Charokopou, Erik Eklund
OBJECTIVE: This study evaluated, in a Swedish setting, the cost effectiveness of fenfluramine (FFA) as an add-on to standard of care (SoC) for reducing seizure frequency in Dravet syndrome, a severe developmental epileptic encephalopathy. METHODS: Cost effectiveness of FFA+SoC compared with SoC only was evaluated using a patient-level simulation model with a lifetime horizon. Patient characteristics and treatment effects, including convulsive seizures, seizure-free days and mortality, were derived from FFA clinical trials...
May 17, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38755403/a-structured-process-for-the-validation-of-a-decision-analytic-model-application-to-a-cost-effectiveness-model-for-risk-stratified-national-breast-screening
#8
JOURNAL ARTICLE
Stuart J Wright, Ewan Gray, Gabriel Rogers, Anna Donten, Katherine Payne
BACKGROUND: Decision-makers require knowledge of the strengths and weaknesses of decision-analytic models used to evaluate healthcare interventions to be able to confidently use the results of such models to inform policy. A number of aspects of model validity have previously been described, but no systematic approach to assessing the validity of a model has been proposed. This study aimed to consolidate the different aspects of model validity into a step-by-step approach to assessing the strengths and weaknesses of a decision-analytic model...
May 16, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38727917/measurement-of-catastrophic-health-expenditure-in-india-a-systematic-review-and-meta-analysis
#9
Umenthala Srikanth Reddy
INTRODUCTION: The escalating burden of catastrophic health expenditure (CHE) poses a significant threat to individuals and households in India, where out-of-pocket expenditure (OOP) constitutes a substantial portion of healthcare financing. With rising OOP in India, a proper measurement to track and monitor CHE due to health expenditure is of utmost important. This study focuses on synthesizing findings, understanding measurement variations, and estimating the pooled incidence of CHE by health services, reported diseases, and survey types...
May 10, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38683438/evolving-evidence-based-value-assessment-of-one-time-therapies-tisagenlecleucel-as-a-case-study
#10
JOURNAL ARTICLE
Theodore Laetsch, Jie Zhang, Hongbo Yang, Yanwen Xie, Dudan Zhang, Louis Garrison
BACKGROUND: Economic evaluation of one-time therapies during reimbursement decision-making is challenging due to uncertain long-term outcomes. The availability of 5-year outcome data from the ELIANA trial and real-world evidence of tisagenlecleucel, the first chimeric antigen receptor T-cell (CAR-T) therapy, presents an opportunity to re-evaluate the predictions of prior cost-effectiveness analyses (CEAs). OBJECTIVE: To conduct a systematic literature review (SLR) of prior CEAs of tisagenlecleucel for pediatric/young adult relapsed or refractory acute lymphoblastic leukemia (r/r ALL) and evaluate the impact of recently available 5-year efficacy data from ELIANA and advances in CAR-T manufacturing in an updated CEA model...
April 29, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38641755/comparison-of-the-measurement-properties-of-eq-5d-5l-and-sf-6dv2-in-covid-19-patients-in-china
#11
JOURNAL ARTICLE
Ningxin Ding, Huixuan Zhou, Chen Chen, Hui Chen, Yunfeng Shi
BACKGROUND AND OBJECTIVES: There are limited studies comparing the health utility values of EQ-5D-5L and SF-6Dv2 within the same patient cohorts. The widespread transmission and recurring infections associated with Omicron variants amid the COVID-19 pandemic have resulted in substantial health detriments and increased utilisation of health care resources. This highlights the crucial need to assess the loss in quality-adjusted life years (QALYs). Therefore, this study aims to compare the ceiling and floor effects, agreement, correlation and responsiveness between EQ-5D-5L and SF-6Dv2 based on COVID-19 patients during the Omicron outbreak in China...
April 19, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38637451/health-economics-in-a-world-of-uneconomic-growth
#12
JOURNAL ARTICLE
Martin Hensher, Gerry McCartney, Eleanor Ochodo
Multiple, accelerating and interacting ecological crises are increasingly understood as constituting a major threat to human health and well-being. Unconstrained economic growth is strongly implicated in these growing crises, and it has been argued that this growth has now become "uneconomic growth", which is a situation where the size of the economy is still expanding, but this expansion is causing more harm than benefit. This article summarises the multiple pathways by which uneconomic growth can be expected to harm human health...
April 18, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38598091/economic-evaluation-of-covid-19-immunization-strategies-a-systematic-review-and-narrative-synthesis
#13
Enxue Chang, Haofei Li, Wanji Zheng, Lan Zhou, Yanni Jia, Wen Gu, Yiyin Cao, Xiaoying Zhu, Juan Xu, Bo Liu, Mao You, Kejun Liu, Mingsi Wang, Weidong Huang
OBJECTIVES: This study aimed to systematically assess global economic evaluation studies on COVID-19 vaccination, offer valuable insights for future economic evaluations, and assist policymakers in making evidence-based decisions regarding the implementation of COVID-19 vaccination. METHODS: Searches were performed from January 2020 to September 2023 across seven English databases (PubMed, Web of Science, MEDLINE, EBSCO, KCL-Korean Journal Dataset, SciELO Citation Index, and Derwent Innovations Index) and three Chinese databases (Wanfang Data, China Science and Technology Journal, and CNKI)...
April 10, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38554246/model-based-economic-evaluations-of-interventions-for-dementia-an-updated-systematic-review-and-quality-assessment
#14
Mohsen Ghaffari Darab, Lidia Engel, Dennis Henzler, Michael Lauerer, Eckhard Nagel, Vicki Brown, Cathrine Mihalopoulos
BACKGROUND: There has been an increase in model-based economic evaluations of interventions for dementia. The most recent systematic review of economic evaluations for dementia highlighted weaknesses in studies, including lack of justification for model assumptions and data inputs. OBJECTIVE: This study aimed to update the last published systematic review of model-based economic evaluations of interventions for dementia, including Alzheimer's disease, with a focus on any methodological improvements and quality assessment of the studies...
March 30, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38530626/the-hidden-toll-of-psychological-distress-in-australian-adults-and-its-impact-on-health-related-quality-of-life-measured-as-health-state-utilities
#15
JOURNAL ARTICLE
Muhammad Iftikhar Ul Husnain, Mohammad Hajizadeh, Hasnat Ahmad, Rasheda Khanam
BACKGROUND: Psychological distress (PD) is a major health problem that affects all aspects of health-related quality of life including physical, mental and social health, leading to a substantial human and economic burden. Studies have revealed a concerning rise in the prevalence of PD and various mental health conditions among Australians, particularly in female individuals. There is a scarcity of studies that estimate health state utilities (HSUs), which reflect the overall health-related quality of life in individuals with PD...
March 26, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38467989/is-economic-evaluation-and-care-commissioning-focused-on-achieving-the-same-outcomes-resource-allocation-considerations-and-challenges-using-england-as-a-case-study
#16
JOURNAL ARTICLE
Matthew Franklin, Sebastian Hinde, Rachael Maree Hunter, Gerry Richardson, William Whittaker
Commissioning describes the process of contracting appropriate care services to address pre-identified needs through pre-agreed payment structures. Outcomes-based commissioning (i.e., paying services for pre-agreed outcomes) shares a common goal with economic evaluation: achieving value for money for relevant outcomes (e.g., health) achieved from a finite budget. We describe considerations and challenges as to the practical role of relevant outcomes for evaluation and commissioning, seeking to bridge a gap between economic evaluation evidence and care commissioning...
March 11, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38448720/cost-effectiveness-of-novel-agent-regimens-for-transplant-eligible-newly-diagnosed-multiple-myeloma-patients-in-india
#17
JOURNAL ARTICLE
Jyoti Dixit, Pankaj Malhotra, Nikita Mehra, Anisha Mathew, Lalit Kumar, Ashish Singh, Nidhi Gupta, Manjunath Nookala Krishnamurthy, Partha Sarathi Roy, Amal Chandra Kataki, Sudeep Gupta, Shankar Prinja
BACKGROUND: Survival outcomes for multiple myeloma have improved dramatically since the introduction of novel therapeutic agents. While these drugs are highly effective in improving survival outcomes and quality of life in patients with multiple myeloma, they come at a significant cost. We assessed the cost-effectiveness of bortezomib-based triplet or quadruplet drug regimens in isolation and followed by autologous hematopoietic stem cell transplantation (AHSCT) for the treatment of newly diagnosed multiple myeloma (NDMM) in the Indian context...
March 7, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38427217/cost-of-low-value-imaging-worldwide-a-systematic-review
#18
Elin Kjelle, Ingrid Øfsti Brandsæter, Eivind Richter Andersen, Bjørn Morten Hofmann
BACKGROUND AND OBJECTIVE: Imaging with low or no benefit for the patient undermines the quality of care and amounts to vast opportunity costs. More than 3.6 billion imaging examinations are performed annually, and about 20-50% of these are of low value. This study aimed to synthesize knowledge of the costs of low-value imaging worldwide. METHODS: This systematic review was based on the PRISMA statement. The database search was developed in Medline and further adapted to Embase-Ovid, Cochrane Library, and Scopus...
March 1, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38427216/-sharingheor-developing-modern-media-for-communication-and-dissemination-of-health-economics-and-outcomes-research
#19
JOURNAL ARTICLE
Davene R Wright, Mikaela Batista, Tim Wrightson
Questions regarding the effectiveness and safety of health interventions and allocation of health care resources are frequently discussed in mainstream and social media. Additionally, government and foundation funders are increasingly mandating that results be disseminated to the lay public and patients may benefit from being able to digest scientific research regarding their health conditions. Therefore, it is important to widely disseminate and clearly communication health economics and outcomes research (HEOR) findings to a range of interested parties...
March 1, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38386271/the-impact-of-raising-alcohol-taxes-on-government-tax-revenue-insights-from-five-european-countries
#20
JOURNAL ARTICLE
Jakob Manthey, Inese Gobiņa, Laura Isajeva, Jarosław Neneman, Rainer Reile, Mindaugas Štelemėkas, Jürgen Rehm
BACKGROUND AND OBJECTIVE: Reducing the affordability of alcoholic beverages by increasing alcohol excise taxation can lead to a reduction in alcohol consumption but the impact on government alcohol excise tax revenue is poorly understood. This study aimed to (a) describe cross-country tax revenue variations and (b) investigate how changes in taxation were related to changes in government tax revenue, using data from Estonia, Germany, Latvia, Lithuania and Poland. METHODS: For the population aged 15 years or older, we calculated the annual per capita alcohol excise tax revenue, total tax revenue, gross domestic product and alcohol consumption...
February 22, 2024: Applied Health Economics and Health Policy
journal
journal
40237
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.